Heretofore, some studies highlighted abnormalities of protein glycosylation in RA [20–22] and, recently, the shift in the glycosylation profile of serum transferrin in RA has been proposed as a biochemical marker of RA activity [23]. The gene discussed is TF; the disease is rheumatoid arthritis.